3 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 3 separate news trends connected to Adc, spanning July 6, 2026 through October 5, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 17 article observations and 17 source signals, led by Business, Health coverage. Use it to compare how individual events emerged, spread and changed over time.
Genmab’s Phase 2 ovarian cancer data fuels claims its ADC could outpace AbbVie’s Elahere, reshaping the platinum‑resistant market.
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Novartis is expanding its antibody-drug conjugate (ADC) pipeline through the acquisition of U.K.-based cancer biotech Myricx Bio for up to $1.5 billion.